
AcelRx Pharmaceuticals, Inc
ACRX
ACRX: AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain.
moreShow ACRX Financials
Recent trades of ACRX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ACRX's directors and management
Government lobbying spending instances
-
$50,000 Jul 20, 2022 Issue: Defense Health Issues
-
$50,000 Apr 20, 2022 Issue: Defense Health Issues
-
$50,000 Jan 18, 2022 Issue: Health Issues Defense
-
$50,000 Oct 23, 2021 Issue: Defense Health Issues
-
$50,000 Jul 22, 2021 Issue: Health Issues Defense
-
$50,000 Apr 20, 2021 Issue: Defense Health Issues
-
$50,000 Jan 20, 2021 Issue: Health Issues Defense
-
$50,000 Oct 20, 2020 Issue: Health Issues Defense
-
$50,000 Jul 20, 2020 Issue: Health Issues Defense
-
$50,000 Apr 21, 2020 Issue: Defense Health Issues
-
$50,000 Jan 21, 2020 Issue: Health Issues
-
$50,000 Oct 18, 2019 Issue: Health Issues
-
$50,000 Jul 12, 2019 Issue: Health Issues
-
$45,000 Apr 04, 2019 Issue: Health Issues
-
$30,000 Jan 09, 2019 Issue: Health Issues
-
$50,000 Oct 10, 2018 Issue: Health Issues
-
$50,000 Jul 09, 2018 Issue: Health Issues
-
$50,000 Apr 06, 2018 Issue: Health Issues
-
$45,000 Jan 12, 2018 Issue: Defense Health Issues
New patents grants
-
Patent Title: Systems, devices and methods for dispensing oral transmucosal dosage forms Jul. 13, 2021
-
Patent Title: Storage and dispensing devices for administration of oral transmucosal dosage forms Jan. 19, 2021
-
Patent Title: Apparatus for administering small volume oral transmucosal dosage forms Jul. 14, 2020
-
Patent Title: Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain Dec. 17, 2019
-
Patent Title: Small-volume oral transmucosal dosage forms Jul. 09, 2019
-
Patent Title: Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain Apr. 02, 2019
-
Patent Title: Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain Aug. 29, 2017
-
Patent Title: Methods and apparatus for administering small volume oral transmucosal dosage forms May. 09, 2017
-
Patent Title: Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain Apr. 26, 2016
-
Patent Title: Methods for administering small volume oral transmucosal dosage forms using a dispensing device Mar. 22, 2016
-
Patent Title: Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same Feb. 03, 2015
-
Patent Title: Drug storage and dispensing devices and systems comprising the same Dec. 09, 2014
-
Patent Title: Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain Oct. 21, 2014
-
Patent Title: Bioadhesive drug formulations for oral transmucosal delivery Oct. 21, 2014
-
Patent Title: Small-volume oral transmucosal dosage forms Jul. 15, 2014
-
Patent Title: Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain Jul. 15, 2014
-
Patent Title: Methods for administering small volume oral transmucosal dosage forms using a dispensing device Jun. 17, 2014
-
Patent Title: Storage and dispensing devices for administration of oral transmucosal dosage forms Nov. 05, 2013
-
Patent Title: Storage and dispensing devices for administration of oral transmucosal dosage forms Oct. 01, 2013
-
Patent Title: Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain Sep. 17, 2013
-
Patent Title: Method of moving a delivery member of a dispensing device for administration of oral transmucosal dosage forms Aug. 06, 2013
-
Patent Title: Drug dispensing device with flexible push rod Jan. 22, 2013
-
Patent Title: Bioadhesive drug formulations for oral transmucosal delivery Aug. 28, 2012
-
Patent Title: Bioadhesive drug formulations for oral transmucosal delivery Aug. 28, 2012
-
Patent Title: Small-volume oral transmucosal dosage Jul. 31, 2012
-
Patent Title: Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain Jul. 24, 2012
-
Patent Title: Small-volume oral transmucosal dosage forms Jun. 19, 2012
Federal grants, loans, and purchases
Followers on ACRX's company Twitter account
Number of mentions of ACRX in WallStreetBets Daily Discussion
Recent insights relating to ACRX
Recent picks made for ACRX stock on CNBC
ETFs with the largest estimated holdings in ACRX
Flights by private jets registered to ACRX